Podcast: <a href="https://www.listennotes.com/podcasts/throughline-npr-MlL5vKFE79B/">Throughline</a> (LS 76 &middot; TOP 0.01% <a href="https://www.listennotes.com/listen-score/">what is this?</a>) Episode: <a href="https://www.listennotes.com/e/26cabc479542489bb918d67c75e789e1/">A Story Of Us?</a> Pub date: 2022-02-03 <img src="https://cdn-images-3.listennotes.com/podcasts/throughline-npr-hImoaxJz5Cn-MlL5vKFE79B.300x300.jpg" width="150" height="150"></img> We've been seeing a lot of debate recently about how history should be taught. For example, some believe that the Civil War was about state rights while some argue that slavery played a large role in it. But what if we could all agree on one shared history? The past, as we know it, is a collection of billions of smaller stories that coalesce into the stories of families, communities, nations, and entire cultures. According to Tamim Ansary, narrative is the way we invent the past and the key to understanding history is understanding the stories we tell ourselves about three key areas: technology, environment, and language. With a world seemingly more connected than ever and still volatile with a constant sense of fracturing identities, Tamim contends that our shared history is a story we must invent. And the future of our species depends on our ability to develop a story we can all see ourselves in. Learn more about sponsor message choices: <a href="https://podcastchoices.com/adchoices">podcastchoices.com/adchoices</a> <a href="https://www.npr.org/about-npr/179878450/privacy-policy">NPR Privacy Policy</a> The podcast and artwork embedded on this page are from NPR, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

<description> &lt;strong&gt;Podcast&lt;/strong&gt;: &lt;a href="https://www.listennotes.com/podcasts/throughline-npr-MlL5vKFE79B/"&gt;Throughline&lt;/a&gt; (LS 76 &amp;middot; TOP 0.01% &lt;a href="https://www.listennotes.com/listen-score/"&gt;&lt;small&gt;what is this?&lt;/small&gt;&lt;/a&gt;)&lt;br&gt;&lt;strong&gt;Episode&lt;/strong&gt;: &lt;a href="https://www.listennotes.com/e/26cabc479542489bb918d67c75e789e1/"&gt;A Story Of Us?&lt;/a&gt;&lt;br&gt;&lt;strong&gt;Pub date&lt;/strong&gt;: 2022-02-03&lt;br&gt;&lt;br&gt;&lt;img src="https://cdn-images-3.listennotes.com/podcasts/throughline-npr-hImoaxJz5Cn-MlL5vKFE79B.300x300.jpg" width="150" height="150"&gt;&lt;/img&gt;&lt;br&gt;&lt;br&gt;We've been seeing a lot of debate recently about how history should be taught. For example, some believe that the Civil War was about state rights while some argue that slavery played a large role in it. But what if we could all agree on one shared history? The past, as we know it, is a collection of billions of smaller stories that coalesce into the stories of families, communities, nations, and entire cultures. According to Tamim Ansary, narrative is the way we invent the past and the key to understanding history is understanding the stories we tell ourselves about three key areas: technology, environment, and language. With a world seemingly more connected than ever and still volatile with a constant sense of fracturing identities, Tamim contends that our shared history is a story we must invent. And the future of our species depends on our ability to develop a story we can all see ourselves in.&lt;br /&gt;&lt;br /&gt;Learn more about sponsor message choices: &lt;a href="https://podcastchoices.com/adchoices"&gt;podcastchoices.com/adchoices&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="https://www.npr.org/about-npr/179878450/privacy-policy"&gt;NPR Privacy Policy&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;small&gt;The podcast and artwork embedded on this page are from NPR, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.&lt;/small&gt;&lt;br&gt; </description>

Throughline


                
Podcast: Throughline
Episode: A Story Of Us?
Pub date: 2022-02-03

Details: https://www.listennotes.com/e/26cabc479542489bb918d67c75e789e1/

The podcast and artwork embedded on this page are from NPR, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

                
            

A Story Of Us?

Podcast: <a href="https://www.listennotes.com/podcasts/throughline-npr-MlL5vKFE79B/">Throughline</a> (LS 76 &middot; TOP 0.01% <a href="https://www.listennotes.com/listen-score/">what is this?</a>) Episode: <a href="https://www.listennotes.com/e/26cabc479542489bb918d67c75e789e1/">A Story Of Us?</a> Pub date: 2022-02-03 <img src="https://cdn-images-3.listennotes.com/podcasts/throughline-npr-TD5Fvu6E2Jn-MlL5vKFE79B.300x300.jpg" width="150" height="150"></img> We've been seeing a lot of debate recently about how history should be taught. For example, some believe that the Civil War was about state rights while some argue that slavery played a large role in it. But what if we could all agree on one shared history? The past, as we know it, is a collection of billions of smaller stories that coalesce into the stories of families, communities, nations, and entire cultures. According to Tamim Ansary, narrative is the way we invent the past and the key to understanding history is understanding the stories we tell ourselves about three key areas: technology, environment, and language. With a world seemingly more connected than ever and still volatile with a constant sense of fracturing identities, Tamim contends that our shared history is a story we must invent. And the future of our species depends on our ability to develop a story we can all see ourselves in. Learn more about sponsor message choices: <a href="https://podcastchoices.com/adchoices">podcastchoices.com/adchoices</a> <a href="https://www.npr.org/about-npr/179878450/privacy-policy">NPR Privacy Policy</a> The podcast and artwork embedded on this page are from NPR, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

<description> &lt;strong&gt;Podcast&lt;/strong&gt;: &lt;a href="https://www.listennotes.com/podcasts/throughline-npr-MlL5vKFE79B/"&gt;Throughline&lt;/a&gt; (LS 76 &amp;middot; TOP 0.01% &lt;a href="https://www.listennotes.com/listen-score/"&gt;&lt;small&gt;what is this?&lt;/small&gt;&lt;/a&gt;)&lt;br&gt;&lt;strong&gt;Episode&lt;/strong&gt;: &lt;a href="https://www.listennotes.com/e/26cabc479542489bb918d67c75e789e1/"&gt;A Story Of Us?&lt;/a&gt;&lt;br&gt;&lt;strong&gt;Pub date&lt;/strong&gt;: 2022-02-03&lt;br&gt;&lt;br&gt;&lt;img src="https://cdn-images-3.listennotes.com/podcasts/throughline-npr-TD5Fvu6E2Jn-MlL5vKFE79B.300x300.jpg" width="150" height="150"&gt;&lt;/img&gt;&lt;br&gt;&lt;br&gt;We've been seeing a lot of debate recently about how history should be taught. For example, some believe that the Civil War was about state rights while some argue that slavery played a large role in it. But what if we could all agree on one shared history? The past, as we know it, is a collection of billions of smaller stories that coalesce into the stories of families, communities, nations, and entire cultures. According to Tamim Ansary, narrative is the way we invent the past and the key to understanding history is understanding the stories we tell ourselves about three key areas: technology, environment, and language. With a world seemingly more connected than ever and still volatile with a constant sense of fracturing identities, Tamim contends that our shared history is a story we must invent. And the future of our species depends on our ability to develop a story we can all see ourselves in.&lt;br /&gt;&lt;br /&gt;Learn more about sponsor message choices: &lt;a href="https://podcastchoices.com/adchoices"&gt;podcastchoices.com/adchoices&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="https://www.npr.org/about-npr/179878450/privacy-policy"&gt;NPR Privacy Policy&lt;/a&gt;&lt;br&gt;&lt;br&gt;&lt;small&gt;The podcast and artwork embedded on this page are from NPR, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.&lt;/small&gt;&lt;br&gt; </description>

Podcast: <a href="https://www.listennotes.com/podcasts/this-week-in-virology-vincent-racaniello-Ks3jv8RuV9l/">This Week in Virology</a> (LS 61 &middot; TOP 0.1% <a href="https://www.listennotes.com/listen-score/">what is this?</a>) Episode: <a href="https://www.listennotes.com/e/f41e27a7821e4dae8410ba9eeb12552c/">TWiV 837: COVID-19 clinical update #91 with Dr. Daniel Griffin</a> Pub date: 2021-12-04 <img src="https://cdn-images-3.listennotes.com/podcasts/this-week-in-virology-vincent-racaniello-xqhVnfGYoIS-Ks3jv8RuV9l.300x300.jpg" width="150" height="150"></img> In COVID-19 clinical update #91, Dr. Griffin discusses final results of molnupiravir trial, Omicron variant of concern, outcomes in B-cell depleted patients, recovery in T-cell depleted macaques, peptide for induction of T cell immunity, high respiratory viral RNA loads in infants, IgA and T cells transferred to breast milk after vaccination, sensitivity and specificity of ID NOW, post-acute sequelae at 12 months, disease in low and middle income countries. Hosts: <a href="http://parasiteswithoutborders.com/">Daniel Griffin</a> and <a href="http://en.wikipedia.org/wiki/Vincent_Racaniello">Vincent Racaniello</a> Subscribe (free): <a href="http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784">iTunes</a>, <a href="https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href="http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a> Become a <a href="https://www.microbe.tv/contribute">patron</a> of TWiV! Links for this episode <ul> <li>Update on <a href="https://www.merck.com/news/merck-and-ridgeback-biotherapeutics-provide-update-on-results-from-move-out-study-of-molnupiravir-an-investigational-oral-antiviral-medicine-in-at-risk-adults-with-mild-to-moderate-covid-19/"> Molnupiravir results</a> (Merck)</li> <li><a href="https://en.wikipedia.org/wiki/SARS-CoV-2_Omicron_variant">Omicron</a> (Wikipedia)</li> <li>P681H and <a href="https://www.biorxiv.org/content/10.1101/2021.11.09.467693v1">IFN resistance</a> (bioRxiv)</li> <li><a href="https://pubmed.ncbi.nlm.nih.gov/34049860/">Synthetic DMARDS</a> and disease severity (Ann Rheum Dis)</li> <li>Recovery in <a href="https://journals.asm.org/doi/epub/10.1128/mBio.01503-21">T cell depleted macaques</a> (mBio)</li> <li><a href="https://www.nature.com/articles/s41586-021-04232-5">T-cell inducing</a> peptide (Nature)</li> <li>Respiratory viral RNA load in <a href="https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab577/6438522"> infants</a> (J Inf Dis)</li> <li>IgA and T cells in <a href="https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00340-2"> breast milk</a> (Cell Rep)</li> <li>ID NOW <a href="https://www.sciencedirect.com/science/article/pii/S1386653221002882?via%3Dihub"> specificity and sensitivity</a> (J Clinical Viral)</li> <li><a href="https://thorax.bmj.com/content/early/2021/11/14/thoraxjnl-2021-217580.long"> Risk prediction</a> algorithm (Thorax)</li> <li>PASC in adults <a href="https://www.frontiersin.org/articles/10.3389/fmed.2021.778434/full"> at 12 months</a> (Front Med)</li> <li><a href="https://www.microbe.tv/twiv/twiv-837-letters/">Letters read</a> on TWiV 837</li> <li>Timestamps by <a href="http://www.twitter.com/jrrmicro">Jolene</a>. Thanks!</li> </ul> Intro music is by <a href="http://www.ronaldjenkees.com/">Ronald Jenkees</a> Send your questions for Dr. Griffin to daniel@microbe.tv The podcast and artwork embedded on this page are from Vincent Racaniello, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

<description> &lt;strong&gt;Podcast&lt;/strong&gt;: &lt;a href="https://www.listennotes.com/podcasts/this-week-in-virology-vincent-racaniello-Ks3jv8RuV9l/"&gt;This Week in Virology&lt;/a&gt; (LS 61 &amp;middot; TOP 0.1% &lt;a href="https://www.listennotes.com/listen-score/"&gt;&lt;small&gt;what is this?&lt;/small&gt;&lt;/a&gt;)&lt;br&gt;&lt;strong&gt;Episode&lt;/strong&gt;: &lt;a href="https://www.listennotes.com/e/f41e27a7821e4dae8410ba9eeb12552c/"&gt;TWiV 837: COVID-19 clinical update #91 with Dr. Daniel Griffin&lt;/a&gt;&lt;br&gt;&lt;strong&gt;Pub date&lt;/strong&gt;: 2021-12-04&lt;br&gt;&lt;br&gt;&lt;img src="https://cdn-images-3.listennotes.com/podcasts/this-week-in-virology-vincent-racaniello-xqhVnfGYoIS-Ks3jv8RuV9l.300x300.jpg" width="150" height="150"&gt;&lt;/img&gt;&lt;br&gt;&lt;br&gt;&lt;p&gt;In COVID-19 clinical update #91, Dr. Griffin discusses final results of molnupiravir trial, Omicron variant of concern, outcomes in B-cell depleted patients, recovery in T-cell depleted macaques, peptide for induction of T cell immunity, high respiratory viral RNA loads in infants, IgA and T cells transferred to breast milk after vaccination, sensitivity and specificity of ID NOW, post-acute sequelae at 12 months, disease in low and middle income countries.&lt;/p&gt; &lt;p&gt;Hosts: &lt;a href="http://parasiteswithoutborders.com/"&gt;Daniel Griffin&lt;/a&gt; and &lt;a href="http://en.wikipedia.org/wiki/Vincent_Racaniello"&gt;Vincent Racaniello&lt;/a&gt;&lt;/p&gt; &lt;p&gt;Subscribe (free): &lt;a href="http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784"&gt;iTunes&lt;/a&gt;, &lt;a href="https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D"&gt;Google Podcasts&lt;/a&gt;, &lt;a href="http://twiv.microbeworld.libsynpro.com/twiv"&gt;RSS&lt;/a&gt;, &lt;a href="http://eepurl.com/Gcw59"&gt;email&lt;/a&gt;&lt;/p&gt; &lt;p&gt;Become a &lt;a href="https://www.microbe.tv/contribute"&gt;patron&lt;/a&gt; of TWiV!&lt;/p&gt; Links for this episode &lt;ul&gt; &lt;li&gt;Update on &lt;a href="https://www.merck.com/news/merck-and-ridgeback-biotherapeutics-provide-update-on-results-from-move-out-study-of-molnupiravir-an-investigational-oral-antiviral-medicine-in-at-risk-adults-with-mild-to-moderate-covid-19/"&gt; Molnupiravir results&lt;/a&gt; (Merck)&lt;/li&gt; &lt;li&gt;&lt;a href="https://en.wikipedia.org/wiki/SARS-CoV-2_Omicron_variant"&gt;Omicron&lt;/a&gt; (Wikipedia)&lt;/li&gt; &lt;li&gt;P681H and &lt;a href="https://www.biorxiv.org/content/10.1101/2021.11.09.467693v1"&gt;IFN resistance&lt;/a&gt; (bioRxiv)&lt;/li&gt; &lt;li&gt;&lt;a href="https://pubmed.ncbi.nlm.nih.gov/34049860/"&gt;Synthetic DMARDS&lt;/a&gt; and disease severity (Ann Rheum Dis)&lt;/li&gt; &lt;li&gt;Recovery in &lt;a href="https://journals.asm.org/doi/epub/10.1128/mBio.01503-21"&gt;T cell depleted macaques&lt;/a&gt; (mBio)&lt;/li&gt; &lt;li&gt;&lt;a href="https://www.nature.com/articles/s41586-021-04232-5"&gt;T-cell inducing&lt;/a&gt; peptide (Nature)&lt;/li&gt; &lt;li&gt;Respiratory viral RNA load in &lt;a href="https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab577/6438522"&gt; infants&lt;/a&gt; (J Inf Dis)&lt;/li&gt; &lt;li&gt;IgA and T cells in &lt;a href="https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00340-2"&gt; breast milk&lt;/a&gt; (Cell Rep)&lt;/li&gt; &lt;li&gt;ID NOW &lt;a href="https://www.sciencedirect.com/science/article/pii/S1386653221002882?via%3Dihub"&gt; specificity and sensitivity&lt;/a&gt; (J Clinical Viral)&lt;/li&gt; &lt;li&gt;&lt;a href="https://thorax.bmj.com/content/early/2021/11/14/thoraxjnl-2021-217580.long"&gt; Risk prediction&lt;/a&gt; algorithm (Thorax)&lt;/li&gt; &lt;li&gt;PASC in adults &lt;a href="https://www.frontiersin.org/articles/10.3389/fmed.2021.778434/full"&gt; at 12 months&lt;/a&gt; (Front Med)&lt;/li&gt; &lt;li&gt;&lt;a href="https://www.microbe.tv/twiv/twiv-837-letters/"&gt;Letters read&lt;/a&gt; on TWiV 837&lt;/li&gt; &lt;li&gt;Timestamps by &lt;a href="http://www.twitter.com/jrrmicro"&gt;Jolene&lt;/a&gt;. Thanks!&lt;/li&gt; &lt;/ul&gt; &lt;p&gt;Intro music is by &lt;a href="http://www.ronaldjenkees.com/"&gt;Ronald Jenkees&lt;/a&gt; Send your questions for Dr. Griffin to daniel@microbe.tv&lt;/p&gt;&lt;br&gt;&lt;br&gt;&lt;small&gt;The podcast and artwork embedded on this page are from Vincent Racaniello, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.&lt;/small&gt;&lt;br&gt; </description>

This Week in Virology


                
Podcast: This Week in Virology
Episode: TWiV 837: COVID-19 clinical update #91 with Dr. Daniel Griffin
Pub date: 2021-12-04

Details: https://www.listennotes.com/e/f41e27a7821e4dae8410ba9eeb12552c/

The podcast and artwork embedded on this page are from Vincent Racaniello, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

                
            

TWiV 837: COVID-19 clinical update #91 with Dr. Daniel Griffin

Podcast: <a href="https://www.listennotes.com/podcasts/this-week-in-virology-vincent-racaniello-Ks3jv8RuV9l/">This Week in Virology</a> (LS 62 &middot; TOP 0.1% <a href="https://www.listennotes.com/listen-score/">what is this?</a>) Episode: <a href="https://www.listennotes.com/e/f41e27a7821e4dae8410ba9eeb12552c/">TWiV 837: COVID-19 clinical update #91 with Dr. Daniel Griffin</a> Pub date: 2021-12-04 <img src="https://cdn-images-3.listennotes.com/podcasts/this-week-in-virology-vincent-racaniello-xqhVnfGYoIS-Ks3jv8RuV9l.300x300.jpg" width="150" height="150"></img> In COVID-19 clinical update #91, Dr. Griffin discusses final results of molnupiravir trial, Omicron variant of concern, outcomes in B-cell depleted patients, recovery in T-cell depleted macaques, peptide for induction of T cell immunity, high respiratory viral RNA loads in infants, IgA and T cells transferred to breast milk after vaccination, sensitivity and specificity of ID NOW, post-acute sequelae at 12 months, disease in low and middle income countries. Hosts: <a href="http://parasiteswithoutborders.com/">Daniel Griffin</a> and <a href="http://en.wikipedia.org/wiki/Vincent_Racaniello">Vincent Racaniello</a> Subscribe (free): <a href="http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784">iTunes</a>, <a href="https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href="http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a> Become a <a href="https://www.microbe.tv/contribute">patron</a> of TWiV! Links for this episode <ul> <li>Update on <a href="https://www.merck.com/news/merck-and-ridgeback-biotherapeutics-provide-update-on-results-from-move-out-study-of-molnupiravir-an-investigational-oral-antiviral-medicine-in-at-risk-adults-with-mild-to-moderate-covid-19/"> Molnupiravir results</a> (Merck)</li> <li><a href="https://en.wikipedia.org/wiki/SARS-CoV-2_Omicron_variant">Omicron</a> (Wikipedia)</li> <li>P681H and <a href="https://www.biorxiv.org/content/10.1101/2021.11.09.467693v1">IFN resistance</a> (bioRxiv)</li> <li><a href="https://pubmed.ncbi.nlm.nih.gov/34049860/">Synthetic DMARDS</a> and disease severity (Ann Rheum Dis)</li> <li>Recovery in <a href="https://journals.asm.org/doi/epub/10.1128/mBio.01503-21">T cell depleted macaques</a> (mBio)</li> <li><a href="https://www.nature.com/articles/s41586-021-04232-5">T-cell inducing</a> peptide (Nature)</li> <li>Respiratory viral RNA load in <a href="https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab577/6438522"> infants</a> (J Inf Dis)</li> <li>IgA and T cells in <a href="https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00340-2"> breast milk</a> (Cell Rep)</li> <li>ID NOW <a href="https://www.sciencedirect.com/science/article/pii/S1386653221002882?via%3Dihub"> specificity and sensitivity</a> (J Clinical Viral)</li> <li><a href="https://thorax.bmj.com/content/early/2021/11/14/thoraxjnl-2021-217580.long"> Risk prediction</a> algorithm (Thorax)</li> <li>PASC in adults <a href="https://www.frontiersin.org/articles/10.3389/fmed.2021.778434/full"> at 12 months</a> (Front Med)</li> <li><a href="https://www.microbe.tv/twiv/twiv-837-letters/">Letters read</a> on TWiV 837</li> <li>Timestamps by <a href="http://www.twitter.com/jrrmicro">Jolene</a>. Thanks!</li> </ul> Intro music is by <a href="http://www.ronaldjenkees.com/">Ronald Jenkees</a> Send your questions for Dr. Griffin to daniel@microbe.tv The podcast and artwork embedded on this page are from Vincent Racaniello, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

<description> &lt;strong&gt;Podcast&lt;/strong&gt;: &lt;a href="https://www.listennotes.com/podcasts/this-week-in-virology-vincent-racaniello-Ks3jv8RuV9l/"&gt;This Week in Virology&lt;/a&gt; (LS 62 &amp;middot; TOP 0.1% &lt;a href="https://www.listennotes.com/listen-score/"&gt;&lt;small&gt;what is this?&lt;/small&gt;&lt;/a&gt;)&lt;br&gt;&lt;strong&gt;Episode&lt;/strong&gt;: &lt;a href="https://www.listennotes.com/e/f41e27a7821e4dae8410ba9eeb12552c/"&gt;TWiV 837: COVID-19 clinical update #91 with Dr. Daniel Griffin&lt;/a&gt;&lt;br&gt;&lt;strong&gt;Pub date&lt;/strong&gt;: 2021-12-04&lt;br&gt;&lt;br&gt;&lt;img src="https://cdn-images-3.listennotes.com/podcasts/this-week-in-virology-vincent-racaniello-xqhVnfGYoIS-Ks3jv8RuV9l.300x300.jpg" width="150" height="150"&gt;&lt;/img&gt;&lt;br&gt;&lt;br&gt;&lt;p&gt;In COVID-19 clinical update #91, Dr. Griffin discusses final results of molnupiravir trial, Omicron variant of concern, outcomes in B-cell depleted patients, recovery in T-cell depleted macaques, peptide for induction of T cell immunity, high respiratory viral RNA loads in infants, IgA and T cells transferred to breast milk after vaccination, sensitivity and specificity of ID NOW, post-acute sequelae at 12 months, disease in low and middle income countries.&lt;/p&gt; &lt;p&gt;Hosts: &lt;a href="http://parasiteswithoutborders.com/"&gt;Daniel Griffin&lt;/a&gt; and &lt;a href="http://en.wikipedia.org/wiki/Vincent_Racaniello"&gt;Vincent Racaniello&lt;/a&gt;&lt;/p&gt; &lt;p&gt;Subscribe (free): &lt;a href="http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784"&gt;iTunes&lt;/a&gt;, &lt;a href="https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D"&gt;Google Podcasts&lt;/a&gt;, &lt;a href="http://twiv.microbeworld.libsynpro.com/twiv"&gt;RSS&lt;/a&gt;, &lt;a href="http://eepurl.com/Gcw59"&gt;email&lt;/a&gt;&lt;/p&gt; &lt;p&gt;Become a &lt;a href="https://www.microbe.tv/contribute"&gt;patron&lt;/a&gt; of TWiV!&lt;/p&gt; Links for this episode &lt;ul&gt; &lt;li&gt;Update on &lt;a href="https://www.merck.com/news/merck-and-ridgeback-biotherapeutics-provide-update-on-results-from-move-out-study-of-molnupiravir-an-investigational-oral-antiviral-medicine-in-at-risk-adults-with-mild-to-moderate-covid-19/"&gt; Molnupiravir results&lt;/a&gt; (Merck)&lt;/li&gt; &lt;li&gt;&lt;a href="https://en.wikipedia.org/wiki/SARS-CoV-2_Omicron_variant"&gt;Omicron&lt;/a&gt; (Wikipedia)&lt;/li&gt; &lt;li&gt;P681H and &lt;a href="https://www.biorxiv.org/content/10.1101/2021.11.09.467693v1"&gt;IFN resistance&lt;/a&gt; (bioRxiv)&lt;/li&gt; &lt;li&gt;&lt;a href="https://pubmed.ncbi.nlm.nih.gov/34049860/"&gt;Synthetic DMARDS&lt;/a&gt; and disease severity (Ann Rheum Dis)&lt;/li&gt; &lt;li&gt;Recovery in &lt;a href="https://journals.asm.org/doi/epub/10.1128/mBio.01503-21"&gt;T cell depleted macaques&lt;/a&gt; (mBio)&lt;/li&gt; &lt;li&gt;&lt;a href="https://www.nature.com/articles/s41586-021-04232-5"&gt;T-cell inducing&lt;/a&gt; peptide (Nature)&lt;/li&gt; &lt;li&gt;Respiratory viral RNA load in &lt;a href="https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab577/6438522"&gt; infants&lt;/a&gt; (J Inf Dis)&lt;/li&gt; &lt;li&gt;IgA and T cells in &lt;a href="https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00340-2"&gt; breast milk&lt;/a&gt; (Cell Rep)&lt;/li&gt; &lt;li&gt;ID NOW &lt;a href="https://www.sciencedirect.com/science/article/pii/S1386653221002882?via%3Dihub"&gt; specificity and sensitivity&lt;/a&gt; (J Clinical Viral)&lt;/li&gt; &lt;li&gt;&lt;a href="https://thorax.bmj.com/content/early/2021/11/14/thoraxjnl-2021-217580.long"&gt; Risk prediction&lt;/a&gt; algorithm (Thorax)&lt;/li&gt; &lt;li&gt;PASC in adults &lt;a href="https://www.frontiersin.org/articles/10.3389/fmed.2021.778434/full"&gt; at 12 months&lt;/a&gt; (Front Med)&lt;/li&gt; &lt;li&gt;&lt;a href="https://www.microbe.tv/twiv/twiv-837-letters/"&gt;Letters read&lt;/a&gt; on TWiV 837&lt;/li&gt; &lt;li&gt;Timestamps by &lt;a href="http://www.twitter.com/jrrmicro"&gt;Jolene&lt;/a&gt;. Thanks!&lt;/li&gt; &lt;/ul&gt; &lt;p&gt;Intro music is by &lt;a href="http://www.ronaldjenkees.com/"&gt;Ronald Jenkees&lt;/a&gt; Send your questions for Dr. Griffin to daniel@microbe.tv&lt;/p&gt;&lt;br&gt;&lt;br&gt;&lt;small&gt;The podcast and artwork embedded on this page are from Vincent Racaniello, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.&lt;/small&gt;&lt;br&gt; </description>

Podcast: <a href="https://www.listennotes.com/podcasts/the-world-prx-zBfGN6FICJo/">The World</a> (LS 57 &middot; TOP 0.5% <a href="https://www.listennotes.com/listen-score/">what is this?</a>) Episode: <a href="https://www.listennotes.com/e/d6f9d862e07b493db9034f8e51b522cb/">The Taliban takes over provincial Afghan capitals at an alarming pace</a> Pub date: 2021-08-13 <img src="https://cdn-images-3.listennotes.com/podcasts/the-world-prx-oN8vbWCt_k0-zBfGN6FICJo.300x300.jpg" width="150" height="150"></img> The Taliban continues to take over provincial capitals in the north with stunning speed. The US is preparing for a rapid evacuation of personnel, and the Biden administration is dispatching 3,000 troops to help. US officials warn that Kabul could fall within 30 days. And a Hazara family tries to flee Afghanistan. Also, the US may soon open up to more foreign travelers, but require proof of vaccination. Here's a thorny question, though: Which vaccines will count? And in Algeria, wildfires that have been raging this week remain largely out of control. The podcast and artwork embedded on this page are from PRX, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

<description> &lt;strong&gt;Podcast&lt;/strong&gt;: &lt;a href="https://www.listennotes.com/podcasts/the-world-prx-zBfGN6FICJo/"&gt;The World&lt;/a&gt; (LS 57 &amp;middot; TOP 0.5% &lt;a href="https://www.listennotes.com/listen-score/"&gt;&lt;small&gt;what is this?&lt;/small&gt;&lt;/a&gt;)&lt;br&gt;&lt;strong&gt;Episode&lt;/strong&gt;: &lt;a href="https://www.listennotes.com/e/d6f9d862e07b493db9034f8e51b522cb/"&gt;The Taliban takes over provincial Afghan capitals at an alarming pace&lt;/a&gt;&lt;br&gt;&lt;strong&gt;Pub date&lt;/strong&gt;: 2021-08-13&lt;br&gt;&lt;br&gt;&lt;img src="https://cdn-images-3.listennotes.com/podcasts/the-world-prx-oN8vbWCt_k0-zBfGN6FICJo.300x300.jpg" width="150" height="150"&gt;&lt;/img&gt;&lt;br&gt;&lt;br&gt;&lt;p&gt;The Taliban continues to take over provincial capitals in the north with stunning speed. The US is preparing for a rapid evacuation of personnel, and the Biden administration is dispatching 3,000 troops to help. US officials warn that Kabul could fall within 30 days. And a Hazara family tries to flee Afghanistan. Also, the US may soon open up to more foreign travelers, but require proof of vaccination. Here's a thorny question, though: Which vaccines will count? And in Algeria, wildfires that have been raging this week remain largely out of control.&lt;/p&gt;&lt;br&gt;&lt;br&gt;&lt;small&gt;The podcast and artwork embedded on this page are from PRX, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.&lt;/small&gt;&lt;br&gt; </description>

The World


                
Podcast: The World
Episode: The Taliban takes over provincial Afghan capitals at an alarming pace
Pub date: 2021-08-13

Details: https://www.listennotes.com/e/d6f9d862e07b493db9034f8e51b522cb/

The podcast and artwork embedded on this page are from PRX, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.

                
            

The Taliban takes over provincial Afghan capitals at an alarming pace


            A curated playlist of podcasts. For educational purpose only and views expressed are not endorsements.
            
        

Dailypod

Details

Recent Episodes